FDA Clearance Tracker · P130001-S009
ColoHealth
Last checked: Nov 20, 2026Latest source record: Mar 19, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Mar 19, 2025
Approved
Time to decision
169 days
Received Oct 1, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P130001-S009
- Device name
- ColoHealth
- Applicant
- New Day Diagnostics, LLC
- Applicant location
- Knoxville, TN
- Received
- Oct 1, 2024
- Decided
- Mar 19, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P130001
Device type
- Device class
- Class III
- Specialty
- Laboratory Medicine & Pathology
FDA's approval statement
As written in FDA's record.
Approval for the rebranding of the medical device previously known as Epi proColon® to ColoHealth.
Source documents
Other decisions for New Day Diagnostics, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Epi proColonPMA
P130001 · Decided Apr 12, 2016 · 1,195 days after receipt
Device type: System, colorectal neoplasia, DNA methylation and hemoglobin detection (PHP) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.